Three Novel Myeloma Therapies: Register Now for the Myeloma Crowd Round Table Webcast on April 24
UPCOMING MC ROUND TABLES - April 23, 2021
Melflufen, Ide-cel CAR T, Venetoclax Register Now Two new drug treatments have recently been approved for myeloma by the U.S... Read More
Treating Myeloma at the Dana-Farber Cancer Institute: Register Now for the Myeloma Crowd Round Table Webcast on May 8
UPCOMING MC ROUND TABLES - April 22, 2021
Insights from a Center of Excellence Register Now Being treated by a myeloma specialist or having one consult with your local physicia... Read More
HealthTree University: Imaging in Myeloma (Part 3 of 3)
HealthTree University: Imaging in Myeloma (Part 3 of 3)
HEALTHTREE - April 15, 2021
Imaging is an important diagnostic tool. This week’s article with videos from HealthTree University covers some of the finer points of imaging, like explo... Read More
Transitioning to Exercise
MUSCLES FOR MYELOMA - April 15, 2021
We’ve covered the benefits of exercise many times- lowers your side effects during treatments, reduces risk of depression and anxiety, improves balance an... Read More
The Importance of Planning For Your Healthcare Costs
MYELOMA COACH - April 14, 2021
It no longer surprises me when I work with a patient to help them figure out how to pay for their treatments for cancer. Understanding that the costs of cancer ... Read More
COVID Vaccine Responses Limited in Blood Cancer Patients
LIFE WITH MYELOMA - April 14, 2021
According to investigators at the University of Pennsylvania School of Medicine, a large percentage of blood cancer patients do not develop adequate antibodies ... Read More
Reducing Infection Risk with CAR T Therapy in Multiple Myeloma
LIFE WITH MYELOMA - April 10, 2021
With the recent FDA approval of Bristol-Myers/Celgene’s Abecma (idecabtagene vicleucel [“ide-cel”]), some of us (myeloma patients)&... Read More
New Blood-Based Circulating Multiple Myeloma Cells Test Launched for Research Purposes
LIFE WITH MYELOMA - April 09, 2021
A new blood-based test to detect Circulating Multiple Myeloma Cells (CMMCs) has been launched for research use by Menarini Silicon Biosystems, an Italian a... Read More
HealthTree University: Imaging in Myeloma (Part 2 of 3)
HEALTHTREE - April 09, 2021
Imaging is an important diagnostic tool in myeloma treatment and myeloma care. It is hard to know, as a patient, what imaging you should be getting, how often, ... Read More
Winners of our Muscles 4 Myeloma MoveSpring March Fitness Challenge
MUSCLES FOR MYELOMA - April 09, 2021
Each year the month of March is recognized as Multiple Myeloma Awareness Month. In honor of such recognition to our warriors and their battles, we put forth a M... Read More
Myeloma Coach Keith Guernsey: Two Time Cancer Survivor and Author
MYELOMA COACH - April 08, 2021
Since posting this article about Myeloma Coach Keith Guernsey, he has had a new book published that we wanted to share. Congratulations Keith! Thank y... Read More
Venetoclax as a Treatment Option for Relapsed Plasma Cell Leukemia Patients
MYELOMA NEWS - April 08, 2021
Plasma Cell Leukemia (PCL) occurs in the setting of either pre-existing multiple myeloma (labeled secondary PCL [sPCL]) or as a newly diagnosed aggressive ... Read More
Isatuximab Now FDA Approved with Kyprolis and Dex for Relapsed/Refractory Myeloma
MYELOMA NEWS - April 06, 2021
This week the FDA approved the use of the anti-CD38 monoclonal antibody isatuximab (Sarclisa) in combination with carfilzomib (Kyprolis) and dexamethasone for r... Read More
. 
